Holthoff; Hans-Peter
Patent Applications and Registrations
Patent applications and USPTO patent grants for Holthoff; Hans-Peter.The latest application filed is for "short cyclic peptides for the treatment of graves' disease".
- Holthoff; Hans-Peter - Martinsried DE
- Holthoff; Hans-Peter - Penzberg DE
- Holthoff; Hans-Peter - Seeshaupt DE
| Patent | Date |
|---|---|
| Short Cyclic Peptides For The Treatment Of Graves' Disease App 20220041692 - Fassbender; Julia ; et al. | 2022-02-10 |
| Cyclic Peptides For The Treatment Of Graves' Disease App 20200071384 - Holthoff; Hans-Peter ; et al. | 2020-03-05 |
| BINDING COMPOUNDS TO HUMAN Beta 1-ADRENORECEPTOR (Beta 1-AR) AND THEIR USE IN MEASUREMENT OF AUTO-ANTI- Beta 1-AR ANTIBODIES App 20140273015 - Holthoff; Hans-Peter ; et al. | 2014-09-18 |
| Fusion Protein App 20130130315 - Gawaz; Meinrad ; et al. | 2013-05-23 |
| Activation specific inhibitors of nf-kb and method of treating inflammatory processes in cardio-vascular diseases App 20060194819 - Munch; Gotz ; et al. | 2006-08-31 |
| Inhibitors of caspase-3-mediated cleavage of essential ventricular myosin light chain App 20050233405 - Moretti, Alessandra ; et al. | 2005-10-20 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 